These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20502136)

  • 1. Tacrolimus-induced polyneuropathy after heart transplantation.
    Labate A; Morelli M; Palamara G; Pirritano D; Quattrone A
    Clin Neuropharmacol; 2010 May; 33(3):161-2. PubMed ID: 20502136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acute peripheral demyelinating polyneuropathy and acute renal failure after administration of FK506].
    Laham G; Vilches A; Jost L; Jost L; Nogués M
    Medicina (B Aires); 2001; 61(4):445-6. PubMed ID: 11563175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic sensorimotor polyneuropathy associated with tacrolimus immunosuppression in renal transplant patients: case reports.
    Bhagavati S; Maccabee P; Muntean E; Sumrani NB
    Transplant Proc; 2007 Dec; 39(10):3465-7. PubMed ID: 18089409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chronic demyelinating polyneuropathy secondary to treatment with tacrolimus].
    Rodríguez-Gómez D; Rodríguez-Rodríguez A; Pérez-Carral O; Lustres-Pérez M; Cid-Rodríguez MC
    Rev Neurol; 2008 Feb 1-15; 46(3):189-90. PubMed ID: 18297634
    [No Abstract]   [Full Text] [Related]  

  • 5. Tacrolimus-related polyneuropathy: case report and review of the literature.
    De Weerdt A; Claeys KG; De Jonghe P; Ysebaert D; Chapelle T; Roeyen G; Jorens PG
    Clin Neurol Neurosurg; 2008 Mar; 110(3):291-4. PubMed ID: 18055100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demyelinating sensorimotor polyneuropathy associated with the use of sirolimus: a case report.
    Bilodeau M; Hassoun Z; Brunet D
    Transplant Proc; 2008 Jun; 40(5):1545-7. PubMed ID: 18589148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymmetric bilateral demyelinating optic neuropathy from tacrolimus toxicity.
    Venneti S; Moss HE; Levin MH; Vagefi MR; Brozena SC; Pruitt AA; Mourelatos Z; Trojanowski JQ; Galetta SL; Balcer LJ
    J Neurol Sci; 2011 Feb; 301(1-2):112-5. PubMed ID: 21112060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distal acquired demyelinating symmetric polyneuropathy progressing to classic chronic inflammatory demyelinating polyneuropathy and response to fludarabine and cyclophosphamide.
    Leitch MM; Sherman WH; Brannagan TH
    Muscle Nerve; 2013 Feb; 47(2):292-6. PubMed ID: 23168526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late-onset tacrolimus-associated cerebellar atrophia in a heart transplant recipient.
    Kaczmarek I; Schmauss D; Sodian R; Beiras-Fernandez A; Oberhoffer M; Daebritz S; Schoenberg SO; Reichart B
    J Heart Lung Transplant; 2007 Jan; 26(1):89-92. PubMed ID: 17234523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumefactive demyelination, an uncommon form of tacrolimus neurotoxicity.
    Kim SH; Kim W; Lee KW; Hong EK; Kim HJ
    Neurology; 2011 Feb; 76(7):672-4. PubMed ID: 21321342
    [No Abstract]   [Full Text] [Related]  

  • 11. Tacrolimus (FK 506)-induced hemolytic uremic syndrome after heart transplantation.
    Walder B; Ricou B; Suter PM
    J Heart Lung Transplant; 1998 Oct; 17(10):1004-6. PubMed ID: 9811409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sural nerve T cells in demyelinating polyneuropathy associated with monoclonal gammopathy.
    Eurelings M; Notermans NC; Wokke JH; Bosboom WM; Van den Berg LH
    Acta Neuropathol; 2002 Feb; 103(2):107-14. PubMed ID: 11810175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin.
    Cornblath DR; Chaudhry V; Griffin JW
    Ann Neurol; 1991 Jul; 30(1):104-6. PubMed ID: 1929221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fever of unknown origin in renal transplant patients with tacrolimus.
    Hochegger K; Rudnicki M; Auinger M; Mark W; Margreiter R; Mayer G; Rosenkranz AR
    Clin Transplant; 2009; 23(4):575-9. PubMed ID: 19191804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive neurological disease induced by tacrolimus in a renal transplant recipient: case presentation.
    Chegounchi M; Hanna MG; Neild GH
    BMC Nephrol; 2006 Mar; 7():7. PubMed ID: 16573841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion to tacrolimus and atorvastatin in cyclosporine-treated heart transplant recipients with dyslipidemia refractory to fluvastatin.
    Skalicka B; Kubanek M; Malek I; Vymetalova Y; Hoskova L; Podzimkova M; Kautzner J
    J Heart Lung Transplant; 2009 Jun; 28(6):598-604. PubMed ID: 19481021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensorimotor neuropathy resembling CIDP in patients receiving FK506.
    Wilson JR; Conwit RA; Eidelman BH; Starzl T; Abu-Elmagd K
    Muscle Nerve; 1994 May; 17(5):528-32. PubMed ID: 7512691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview of tacrolimus-based immunosuppression after heart or lung transplantation.
    Reichenspurner H
    J Heart Lung Transplant; 2005 Feb; 24(2):119-30. PubMed ID: 15701425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe axonal polyneuropathy after a FK506 overdosage in a lung transplant recipient.
    Boukriche Y; Brugière O; Castier Y; Stocco J; Mal H; Fournier M
    Transplantation; 2001 Dec; 72(11):1849-50. PubMed ID: 11740402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of tacrolimus-related hypertrophic obstructive cardiomyopathy 5 years after kidney transplant in a 6-year-old recipient.
    Jarzembowski TM; John E; Panaro F; Manzelli A; Cabrera A; Greco A; Varga P; Sankary H; Testa G; Benedetti E
    Pediatr Transplant; 2005 Feb; 9(1):117-21. PubMed ID: 15667624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.